Release Date: December 23, 2025
Expiration Date: December 23, 2026
Activity Overview
This online, on-demand virtual symposium brings together renowned experts in the treatment of Demodex blepharitis. In this educational program, these experts review the diagnostic steps for Demodex blepharitis and discuss the efficacy and safety of available agents to address this common disorder.
This educational activity is an archive of the live symposium held on October 17, 2025.
Target Audience
These educational activities are directed toward optometrists, ophthalmologists, and other health care professionals who are involved in the management of patients with neovascular retinal diseases.
Learning Objectives
Upon successful completion of this activity, you should be better prepared to:
- Summarize the disease burden in patients with Demodex blepharitis
- Assess objective and subjective clinical findings to establish a diagnosis of Demodex blepharitis
- Implement targeted therapies in treatment plans to eradicate Demodex and improve outcomes in patients with Demodex blepharitis
Mile Brujic, OD, FAAO
Premier Vision Group
Bowling Geen, OH
Advisor, Consultant, Speaker, Honoraria Recipient: ABB Optical, AbbVie, Alcon, Apellis, Art Optical, Bausch + Lomb Health, Contamac, CooperVision, CS Eye, Dompe, Dopavision, Glaukos, Iveric Bio, Johnson & Johnson Vision Care, Lentechs, MDelite, Nordic Pharma, Notal Vision, Orasis, Radius XR, RVL, Sun Pharma, Tangible Science, Tarsus, Viatris, Visionix, Walman Optical, Zea Vision
Blair Lonsberry, MS, OD, MEd, FAAO
Professor of Optometry
Pacific University College of Optometry
Forest Grove, OR
Advisor, Consultant, Speaker, Honoraria Recipient: AbbVie, Apellis, Dompe, Sun, Thea Pharmaceuticals
Faculty, Staff, and Planners’ Disclosures
The staff of Physicians’ Education Resource®, LLC, have no relevant financial relationships with ineligible companies.
PER® mitigated all COI for faculty, staff, and planners prior to the start of this activity by using a multistep process.
Off-Label Disclosure and Disclaimer
This activity may or may not discuss investigational, unapproved, or off-label use of drugs. Learners are advised to consult prescribing information for any products discussed. The information provided in this accredited activity is for continuing education purposes only and is not meant to substitute for the independent clinical judgment of a health care professional relative to diagnostic, treatment, or management options for a specific patient’s medical condition. The opinions expressed in the content are solely those of the individual faculty members and do not reflect those of PER® or any company that provided commercial support for this activity.
GET STARTED WITH THIS PROGRAM:
Register now to gain access to this program.
Create AccountAlready Registered? Login Here